Podcasts about scientific officer

Today, Brent sits down with Dr. Otis Brawley, a professor of oncology and epidemiology at Johns Hopkins University and former Chief Medical and Scientific Officer of the American Cancer Society. Dr. Brawley shares his expertise on cancer screening, shedding light on the often-overlooked risks of over-screening and unnecessary medical interventions. He challenges conventional wisdom, exploring how screenings can sometimes cause more harm than good and emphasizing the importance of evidence-based approaches to prevention and early detection. This conversation with Dr. Brawley highlights the need for prioritizing lifestyle changes, such as diet and exercise, over reliance on medical screenings alone. Hope you enjoy.

The Government's cracking down on dog owners tying up pets for too long. MPI and SPCA Animal Welfare Inspectors will now be able to issue fines topping $1,000. The regulation targets dogs tethered in poor conditions with signs of mistreatment like excessive barking. SPCA Scientific Officer Dr Alison Vaughan told John MacDonald that the regulations won't be targeting people who tether their togs temporarily, such as when they pop out to the shops. She says the issue is prolonged tethering, sometimes known as life chaining, in which dogs are living out their whole lives on a chain. LISTEN ABOVE See omnystudio.com/listener for privacy information.

Marking World TB Day 2025, this episode explores the data on tuberculosis in Europe based on the latest surveillance report, published recently by ECDC and WHO.Veronica Cristea, Scientific Officer at ECDC, discusses the overall TB situation in the EU/EEA, the impact of COVID-19, challenges in treatment success, and the concerning rise in TB cases among children. Veronica also highlights the steps needed to accelerate progress towards ending TB.Find out more about World TB Day here.For more information about ECDC in general, visit ⁠⁠⁠ecdc.europa.eu⁠⁠⁠⁠⁠⁠⁠⁠⁠ or follow us on ⁠⁠⁠⁠⁠⁠⁠⁠⁠social media⁠⁠⁠⁠⁠⁠⁠⁠⁠.

The National Standards Authority of Ireland (NSAI), in conjunction with their partners Data Edge, Timing Solutions and HEAnet, are hosting Ireland's inaugural Time & Sync Forum today, 11th Feb 2025, in Santry, Dublin. The event is bringing together a number of leading authorities in timing and synchronisation from Ireland, the UK and the European Commission to discuss key topics and policies relating to critical infrastructure on the island of Ireland. Position, Navigation, and Timing (PNT) technologies play a crucial role in modern economies, and enable over 10% of Europe's annual GDP, or more than €14 trillion*. Major industries such as communications, energy, transportation, public services and financial services are increasingly reliant on precise timing and timing distribution to deliver their services. Commenting on the event, Minister for Enterprise, Tourism and Employment, Peter Burke TD said, "Position, Navigation and Timing technologies are a core part of the work of a number of industries that are cornerstones of the Irish economy. Earlier this year, the Programme for Government committed to delivering a strong enterprise and fiscal framework to support competitiveness and the growth of a strong industrial base which has created jobs, grown exports, promoted innovation, and raised our standard of living. I warmly welcome this event, focussed on building on the launch of the National Timing Grid, and its role in advancing Ireland's domestic capabilities to support industry." Following on from the successful launch of Ireland's first National Timing Grid in 2023, the NSAI is hosting the Forum to promote the continuing need for Ireland to have as much control over its timing infrastructure as possible, including the potential replacement of Greenwich Mean Time with a domestic equivalent. Keynote speakers include Dr. Leon Lobo, Head of the National Timing Centre (NTC) programme at Britain's National Physical Laboratory, who is delivering its national timing strategy. Dr. Lukasz Bonenberg, Space Programmes Policy and Scientific Officer, Joint Research Centre (JRC), European Commission, will also provide his expertise having worked on Galileo, the EU's Global Navigation Satellite System (GNSS). Between them, Drs. Lobo and Bonenberg will provide an important overview of PNT resiliency across Europe. Along with Data Edge, Timing Solutions and HEAnet, NSAI are currently working on enhancing Ireland's PNT capabilities through the National Timing Grid and the distribution of verified global GNSS data to support compliance with the upcoming EU NIS2 Directive. This update to the EU's original Network and Information Security (NIS) Directive significantly expands cybersecurity obligations for critical infrastructure sectors. NSAI's National Metrology Laboratory (NML), based in Glasnevin, maintains the reference measurement standards for Time & Frequency and contribute their atomic clock data to the International Bureau for Weights and Measures (BIPM) who maintain and calculate Coordinated Universal Time (UTC). Whilst Legal Time in Ireland is under the remit of the Department of Justice, the internationally accepted representation of the second in Ireland is maintained by the NSAI's NML. David Fleming, National Standards Authority of Ireland, Technical Manager for Time, said, "We expect this important gathering to provide valuable insights which help us to inform policy development at a Governmental level and outline the requirements for investment in key timing infrastructure for the country. In a time of disruption and major technological advancements, Ireland needs to be as self-sufficient in this area as possible, while also aligning fully with our international counterparts." "With this event, we are aiming to draw in and engage as many interested stakeholders as possible to determine the requirements across the diverse sectors dependent upon precise timing." See more stories here.

This week, Brent sits down with Dr. Otis Brawley, a professor of oncology and epidemiology at Johns Hopkins University and former Chief Medical and Scientific Officer of the American Cancer Society. Dr. Brawley shares his expertise on cancer screening, shedding light on the often-overlooked risks of over-screening and unnecessary medical interventions. He challenges conventional wisdom, exploring how screenings can sometimes cause more harm than good and emphasizing the importance of evidence-based approaches to prevention and early detection.  This conversation with Dr. Brawley highlights the need for prioritizing lifestyle changes, such as diet and exercise, over reliance on medical screenings alone. Whether you're navigating personal health decisions or curious about the future of preventive care, this episode offers a balanced perspective on optimizing health without falling into the trap of over-testing. Hope you enjoy.

Today, I am blessed to dive into the fascinating world of stem cells with Dr. Rafael Gonzalez, the Chief Development and Scientific Officer at Rehealth. We explore the crucial role of stem cells in anti-aging, immune support, and metabolic health. Dr. Gonzalez explains how stem cells function, their impact on longevity, and the benefits of fasting on stem cell production. We also discuss practical strategies like adopting a low-carb diet and regular exercise to boost stem cell function naturally. This episode offers valuable insights and actionable tips for enhancing overall health and well-being.

I sit down with Dr. Patrick Soon-Shiong, Executive Chairman and Global Chief Medical and Scientific Officer for Immunity Bio, and we talk everything cancer vaccines scientifically, including the potential Lynch Syndrome vaccine.  A new term is announced on our podcast, Tumor Educated Lymphocytes.  Dr Soon-Shiong, succinctly summarized a very complicated vaccine space, which will be important as more patients enroll in trials and learn about their genetics.  

In this episode, Ayesha spoke with Shaheen Lakhan, MD, PhD, Chief Medical and Scientific Officer, Click Therapeutics, a company focused on developing software as prescription medical treatments for people with unmet medical needs. Click Therapeutics is specifically developing Digital Therapeutics, which involve the delivery of prescription treatments to patient's smartphones. These are being developed for indications in psychiatry, neurology, oncology, immunology and cardiometabolic diseases. In collaboration with Otsuka, Click Therapeutics most recently developed the first prescription digital therapeutic authorized by the FDA for the adjunctive treatment of major depressive disorder symptoms. Dr. Lakhan, is an inventive entrepreneurial physician-scientist who is board-certified in neurology and pain medicine with over 20 years of industry experience. As Chief Medical and Scientific Officer at Click Therapeutics and a Board Director at SpineThera, he spearheads AI-enabled clinical development and drug-delivery platforms. Tune in to the episode to hear more the cutting-edge new field of digital therapeutics and how they are shaping the industry. For more life science and medical device content, visit the Xtalks Vitals homepage. https://xtalks.com/vitals/ Follow Us on Social Media Twitter: https://twitter.com/Xtalks Instagram: https://www.instagram.com/xtalks/ Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured

Dr. Otis Brawley, Bloomberg Distinguished Professor of oncology and epidemiology at Johns Hopkins University, is passionate about cancer research, prevention and high-quality cancer care. He served as Chief Medical and Scientific Officer and Executive Vice President of the American Cancer Society from 2007 to 2018 and has published over 200 scientific articles.   In this episode, Dr. Brawley speaks about the impact of socioeconomic factors on cancer rates. Smoking, obesity and poverty are leading causes of cancer in the United States. With cancer rates rising, Dr. Brawley emphasizes the importance of prevention and risk reduction, including healthy lifestyle choices such as regular exercise and a healthy diet. Dr. Brawley is passionate about reducing cancer care disparities and saving lives with accessible, high-quality care, including appropriate screening, diagnostics and treatments. Having the correct data and technology in place can help to identify high-risk individuals and plan interventions early to prevent diseases. Lastly, Dr. Brawley shares valuable insights on carcinogens and practical tips on how to prevent cancer.

A West Clare river has been deemed to be in "bad condition" due to agricultural run-off and wastewater treatment. The Environmental Protection Agency's new report on water quality in rivers and lakes across the country last year has found that increased nutrient pollution means water quality here isn't improving. The Annagh River in West Clare is one of four river water bodies reported as in bad condition along with the River Laune in Kerry, Ahavarraga Stream in Limerick and the Nenagh River in Tipperary. Scientific Officer in the EPA's Water Management Programme Hugh Feeley has been telling Clare FM's Seán Lyons that while farmers must do their bit to prevent run-off, more action is needed from central government.

Sign up for the COVID-UPP Study: https://redcap.nova.edu/redcap/surveys/?s=RMEDJ7LKCX&_gl=1*1h830h7*_gcl_au*MTM2NDA0MTQyOS4xNzE1MDA0ODAy   Can stem cell therapy help repair a fatigued immune system?   Dr. Rafael Gonzalez, an immunology expert and Chief Development and Scientific Officer at TheBioBox & RESTEM, explains how regenerative treatments, such as stem cell therapy, can restore immune function, discussing their potential to reverse age-related decline and balance the immune system after an illness or injury.   Haylie Pomroy and Dr. Gonzalez also discuss the concept of immune system fatigue and its implications for chronic illnesses like chronic fatigue syndrome (CFS) and Long COVID. Theyalso explore the ongoing clinical trials, including studies on autoimmune diseases and the potential of cell therapy in managing autoimmune disorders.   If you are interested in joining a Gulf War Illness (GWI) trial, please complete the Recruitment Registry Form. https://redcap.nova.edu/redcap/surveys/?s=Y9YF8JJWJRK8HEKL%20&_gl=1*1fipp18*_gcl_aw*R0NMLjE3MDc5MTgwMzIuRUFJYUlRb2JDaE1JeWNyUXVfcXFoQU1WU1pCYUJSM3AyQWRBRUFBWUFTQUFFZ0s1NWZEX0J3RQ..*_gcl_au*MTg2NjgwMDQ4Ni4xNzA3MTQwNzgx   Learn more about INIM's Research Studies: https://www.nova.edu/nim/research-studies/index.html   —-------------------------------------------------------------------------------------------   Thank you for tuning in to the Hope and Help For Fatigue and Chronic Illness Podcast. Sign up today for our newsletter.

It's hard to imagine a world without plastic now – plastic exists in almost every sphere of our life. Microplastics, the tiny toxic particles that plastics shed and that are scattered across the environment have been found everywhere – from clouds, to the bottom of the ocean, in Antarctica and even in our bodies – we swallow them and we breathe them in. In a recent study published in The New England Journal of Medicine however, researchers found microplastics and nanoplastics – which are even smaller particles – inside our innermost organ -- in the fatty deposits or plaques that can accumulate in the blood vessels of the heart. They also found that those with these plastics in their blood vessels had a greater risk of experiencing heart attacks, strokes or death. However, they have cautioned this was only a link and not proof that plastics led to bad health – much more research is needed to establish how plastics really affect our health. The study comes at a time when the world and India is attempting to ban plastic and encourage people towards sustainable, plastic-free options – but this is happening very slowly, as we can see all around us, in daily life and in the massive landfills in our city. What can micro and nanoplastics do to the human body? What is the direction research into this must take? And how can we minimise our exposure to plastic pollution? Guest: Dr Sanjay Rajagopalan, one of the authors of the study and Chief, Cardiovascular Medicine and Chief Academic and Scientific Officer at University Hospitals, Harrington Heart & Vascular Institute, Ohio, United States Host: Zubeda Hamid

The CPG Guys are joined in this episode by James H. Dickerson, PhD, former Chief Scientific Officer at Consumer Reports.Follow James on LinkedIn at: https://www.linkedin.com/in/james-h-dickerson-phd/James answers these questions:Would you walk our audience through some of the pivotal professional experiences in your career that have led you to AMTIL?Can you share your most memorable experience during your tenure as Chief Scientific Officer at Consumer Reports?How did you navigate the balance between scientific rigor and communicating findings to the general public?What do you consider the most significant achievement in advancing consumer awareness and safety during your time at Consumer Reports?‘How did you approach incorporating emerging technologies into Consumer Reports' testing methodologies?What role do you see consumer advocacy organizations playing in shaping industry standards and regulations?How did you prioritize the testing and evaluation of products to address the most pressing consumer concerns?Can you share any insights into the future of consumer advocacy and the role of scientific officers in shaping it?CPG Guys Website: http://CPGguys.comFMCG Guys Website: http://FMCGguys.comCPG Scoop Website: http://CPGscoop.comNextUp Website: http://NextUpisnow.org/cpgguysRetailWit Website: http://retailwit.comRhea Raj's Website: http://rhearaj.comDISCLAIMER: The content in this podcast episode is provided for general informational purposes only. By listening to our episode, you understand that no information contained in this episode should be construed as advice from CPGGUYS, LLC or the individual author, hosts, or guests, nor is it intended to be a substitute for research on any subject matter. Reference to any specific product or entity does not constitute an endorsement or recommendation by CPGGUYS, LLC. The views expressed by guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent.  CPGGUYS LLC expressly disclaims any and all liability or responsibility for any direct, indirect, incidental, special, consequential or other damages arising out of any individual's use of, reference to, or inability to use this podcast or the information we presented in this podcast.

PETER MCCULLOUGH, Board Certified Cardiovascular Diseases and Clinical Lipidology Expert, Former Chief Academic and Scientific Officer, St. John Providence Health System, President, Cardiorenal Society of America, @P_McCulloughMD What is "Disease X"? How the "biopharmaceutical complex" is profit-driven A recent admission by Anthony Fauci regarding the development of COVID-19 A new "power grab" by the World Health Organization JONATHAN EMORD, Constitutional law attorney and author of The Authoritarians: Their Assault on Individual Liberty, the Constitution, and Free Enterprise from the 19th Century to the Present (2021) New action taken by Greg Abbott to enhance border security Are other states following the steps of Texas to protect their borders? Would President Biden federalize the National Guard "against" Texas? CHUCK DEVORE, Vice President of National Initiatives, Texas Public Policy Foundation Was the border crisis predicted by some people? A "shift" in the traffic of illegal immigration Why does the U.S. have troops in Jordan? How the Chinese government has made it "impossible" to take any of their economic numbers seriously

In this Making Leaders podcast, we hear from Onyinye Nwankwo, PhD Candidate in Atmospheric and Space Sciences at the University of Michigan, Ann Arbor and one of three Promise Award Recipients in 2023. Onyinye is an accomplished scientist in the field of upper atmospheric and space sciences, currently pursuing her PhD in Climate and Space Sciences and Engineering. She completed her Bachelor's degree in Physics and Industrial Physics at Nnamdi Azikiwe University in her home country of Nigeria before obtaining a Master's degree in Space Geophysics from the National Institute for Space Research (INPE) in Brazil and a second Master of Science in Climate and Space Sciences and Engineering from the University of Michigan. During her undergraduate studies, Onyinye served as an industrial trainee “Radio Signal Officer” at the Nigeria Port Authority in Lagos State, where her skills in maintaining radio signals and signal processing were key to ensuring efficient communication and navigation services. She went on to become a Scientific Officer with the Center for Atmospheric Research, National Space Research and Development Agency (CAR-NASRDA) in Anyibga, Kogi State, Nigeria, where she showcased her expertise in data processing, management and the operation of cutting-edge imaging technology. In this role, Onyinye provided key raw data handling for the All-Sky Airglow Imager and Fabry Perot Interferometer and made significant contributions to the understanding of atmospheric phenomena, which also bolstered Nigeria's stature in space and atmospheric research. Before joining CAR-NASRDA, she worked as a Graduate Assistant in the Department of Physics at Michael Okpara University of Agriculture in Umudike, Nigeria, where she handled a range of responsibilities for the department, including course instruction, design and implementation of research methodologies, contributions to lab experiments and management of administrative tasks.

Host Dr. Narjust Florez interviews new IASLC Chief Scientific Officer Dr. Jennifer King. In this podcast episode, Dr. King shares her perspective on how she intends to direct, guide, and support the scientific strategy of the IASLC.

Dr Widgerow, a plastic surgeon from South Africa, discusses the genesis of Alastin Skincare and the latest product launch.  He has challenged and changed the industry…don't miss this one!  See omnystudio.com/listener for privacy information.

PSC Partners Seeking a Cure is pleased to present Living With PSC, a podcast moderated by Niall McKay. Each month, this podcast explores the latest research and knowledge about primary sclerosing cholangitis (PSC), a rare liver disease. From patient stories, to the latest research updates from PSC experts, to collaborations that are necessary to find better treatments and a cure, this podcast has it all! In episode 41 of the Living with PSC Podcast, Host Niall McKay talked with Dr. Stephen Rossi, Chief Scientific Officer for PSC Partners. In addition to Dr. Rossi's background, the two discussed PSC Partners research priorities and the progress of work being done worldwide to find treatments and a cure for PSC.   "It's exciting to not only take what I've learned on the industry side and the clinical side, but actually work directly with the patient community," says Dr. Rossi. "There's alot of positive things evolving. I'd say, in the next five years, we're going to see a big breakthrough."  

Ashlie Burkart | Chief Scientific Officer at Germin8 Ventures (repost)

This is quite simply a master class in collaborative innovation to solve meaningful challenges. Dr. Simon is a practicing cardiologist, the President of Academic & External Affairs and Chief Scientific Officer for the University Hospitals Health System (UH). We discuss the unique non-profit, for-profit model of The Oxford-Harrington Rare Disease Centre's Therapeutics Accelerator. The Accelerator is a first-of-its-kind, transatlantic initiative to identify, fund and advance breakthrough academic discoveries to deliver new treatments for the 400 million people worldwide who suffer from rare diseases.

In this Better Satellite World podcast series, we ask the question: "What would you do if you had the power to make the world a better place during your career?" Joining SSPI's Lou Zacharilla to answer that question in the first episode are 3 members of the "20 Under 35" cohort of 2023: Onyinye Nwankwo, Atmospheric and Space Scientist at the University of Michigan, Ann Arbor; Amy Comeau, Lead Member of Boeing's CST-100 Starliner Chief Engineer's Office; and Dr. Justyna Kosianka, Senior Remote Sensing Scientist at Ursa Space Systems. Onyinye Nwankwo is an accomplished scientist in the field of upper atmospheric and space sciences, currently pursuing her PhD in Climate and Space Sciences and Engineering at the University of Michigan, Ann Arbor. She completed her Bachelor's degree in Physics and Industrial Physics at Nnamdi Azikiwe University in her home country of Nigeria before obtaining a Master's degree in Space Geophysics from the National Institute for Space Research (INPE) in Brazil and a second Master of Science in Climate and Space Sciences and Engineering from the University of Michigan. During her undergraduate studies, Onyinye served as an industrial trainee “Radio Signal Officer” at the Nigeria Port Authority in Lagos State, where her skills in maintaining radio signals and signal processing were key to ensuring efficient communication and navigation services. She went on to become a Scientific Officer with the Center for Atmospheric Research, National Space Research and Development Agency (CAR-NASRDA) in Anyibga, Kogi State, Nigeria, where she showcased her expertise in data processing, management and the operation of cutting-edge imaging technology. In this role, Onyinye provided key raw data handling for the All-Sky Airglow Imager and Fabry Perot Interferometer and made significant contributions to the understanding of atmospheric phenomena, which also bolstered Nigeria's stature in space and atmospheric research. Before joining CAR-NASRDA, she worked as a Graduate Assistant in the Department of Physics at Michael Okpara University of Agriculture in Umudike, Nigeria, where she handled a range of responsibilities for the department, including course instruction, design and implementation of research methodologies, contributions to lab experiments and management of administrative tasks. Onyinye was selected as one of the three Promise Award Recipients for the 2023 "20 Under 35" cohort. Amy Comeau is a lead member of the CST-100 Starliner Chief Engineer's Office at Boeing, a position that requires solving complex system-level design and integration challenges. As part of her current role, she facilitates factory tours of the Starliner program for key stakeholders, including legislators, community leaders, national and international customers, universities and other organizations, making constant use of her powerful communication and leadership skills. Amy began her career at Boeing in 2018 as a satellite systems vehicle engineer as part of a rotation program, where she led an in-depth analysis of test equipment anomalies and supported the setup and functional checkouts of various satellite payloads. Before joining Boeing, she worked in a fellowship for start-up Bryce Space and Technology as a Brooke Owens fellow – one of only 36 women selected for the fellowship in 2017. She also participated in NASA's Micro-g NExT challenge as a student, during which she designed, developed and manufactured a tool that could seal micrometeorite debris holes on the International Space Station. Amy graduated from Purdue University with a Bachelor of Science in Aeronautical and Astronautical Engineering. Dr. Justyna Kosianka is a Senior Remote Sensing Scientist at Ursa Space Systems, with a history of designing and developing algorithms for Synthetic Aperture Radar (SAR) analytics, geospatial modeling for synthetic SAR training data generation and data fusion. Within this she has focused on change detection as well as environmental monitoring analytics. Dr. Kosianka serves as the manager for Ursa's SAR-based Analytics Team and has served as the technical lead for the company's suite of SAR-based Earth observation analytics, including National Catastrophe, soil moisture, stockpile measurement, flood mapping, well monitoring and oil storage measurement and supply chain management. She was recently assigned the role of Product Owner for Ursa's commodities-based product offerings. In this role, Dr. Kosianka is responsible for planning for design and development of commodities and Earth observation products, which helps set the direction for an entire suite of SAR-analytics-based products for the company. She has made particular progress in the area of 3D Change Detection while at Ursa, resulting in her being awarded 2 patents for SATELLITE SAR ARTIFACT SUPPRESSION FOR ENHANCED THREE-DIMENSIONAL FEATURE EXTRACTION, CHANGE DETECTION, AND VISUALIZATIONS (A-1 and B-1).

On this episode of The Healthcare Plus Podcast, Quint Studer hosts special guest Dr. David Grenache, Chief Scientific Officer of TriCore Reference Laboratories. Quint and David discuss how to replicate best practices, both in leadership and in medicine. Dr. Grenache shares examples of where he's driven change through the implementation of best practices and how he guided his team through those transformations.In their conversation, Dr. Grenache also shares valuable insights on:The critical role laboratory professionals play in predictive and preventative careThe role of AI in healthcareAnd the importance of leveraging tools and insights from laboratory data to impact population healthAbout David G. Grenache, PhD Dr. Grenache is the chief scientific officer for TriCore Reference Laboratories in Albuquerque, New Mexico. In that role, he leads the TriCore Research Institute which helps to innovate healthcare through cutting-edge clinical device trials, advanced central lab services, and a sample biorepository. He is also the laboratory director of TriCore's flagship core laboratory, the medical director of immunology and of point-of-care testing, and a clinical professor of pathology at the University of New Mexico. He is a past president of the Association for Diagnostics and Laboratory Medicine, formerly known as the American Association for Clinical Chemistry. His term as president coincided with the coronavirus pandemic of 2020 and, as such, he helped lead the association through a period of turbulence and uncertainty. Dr. Grenache earned his PhD in biomedical sciences from WPI in Worcester, Massachusetts, and completed postdoctoral training in clinical chemistry at Washington University School of Medicine in St. Louis, Missouri. He has published over 100 research articles, abstracts, and book chapters and is frequently invited to speak at scientific meetings. His research interests are centered on leveraging longitudinal laboratory data to gain insights into individual and population health and the diagnostic tests used to manage the pregnant patient.

We are sinking in heavy weather. Elders are up to 75% of climate-driven fatalities in developed world disasters. Seniors expert Danielle Arigoni on her new book book “Climate Resilience for an Aging Nation”. Then Lauren Stuart, Scientific Officer for the World Meteorological Organization  …

Today we discuss evidence-based approaches that use food and the gut microbiome to promote health and treat disease with Christopher Damman, MD, MA, a board-certified gastroenterologist and internist at the Digestive Health Center at the University of Washington Medical Center and CMO, Scientific Medical & Scientific Officer at Uplifting Results Labs. Dr. Damman is a physician scientist with a particular interest in the microbiome and functional foods. Earlier in 2023, he gave a talk on the clinical application of the evidence base for dietary and microbial interventions to support well-being at our 6th Annual Sung Symposium: The Gut, Microbes, & Well-being. Dr. Damman has a particular interest in the microbiome & functional foods, and he explores these themes as Editor-In-Chief at Gut Bites MD. He's also a clinical associate professor of Medicine at the University of Washington and entrepreneur with 20+ years of experience across the private, philanthropic, and academic sectors. ◘ Related Links Dr. Dammen's Bio & Research Page https://bit.ly/3G2f76u Gut Bites MD https://gutbites.org/ Hangry bacteria in your gut microbiome are linked to chronic disease—feeding them these nutrients could lead to a healthier body https://bit.ly/3unqMuc VIDEOS | 2023 Sung Symposium: The Gut, Microbes, & Well-being https://bit.ly/SungVideos Uplifting Results Labs https://bit.ly/46pOjaV ◘ Transcript bit.ly/45OtWE6 ◘ This podcast features the song “Follow Your Dreams” (freemusicarchive.org/music/Scott_Ho…ur_Dreams_1918) by Scott Holmes, available under a Creative Commons Attribution-Noncommercial (01https://creativecommons.org/licenses/by-nc/4.0/) license. ◘ Disclaimer: The content and information shared in GW Integrative Medicine is for educational purposes only and should not be taken as medical advice. The views and opinions expressed in GW Integrative Medicine represent the opinions of the host(s) and their guest(s). For medical advice, diagnosis, and/or treatment, please consult a medical professional.

Welcome to Becker's Healthcare Podcast, where we delve into the heart of healthcare innovations. In this episode, join us as we engage with Dr. Helen Egger, Co-founder and Chief Medical and Scientific Officer of Little Otter, a pioneering institution in children's mental health. Dr. Egger sheds light on the challenges hospitals and health systems encounter while addressing children's mental health needs. She unveils Little Otter's distinctive philosophy and methodology that emphasize early identification through dedicated resources and intricate processes. Discover the pivotal role telehealth's evolution has played in shaping Little Otter's practices. Tune in to grasp insightful steps that hospitals and health systems can adopt when treating children dealing with suicide ideation.

We couldn't think of a better way to kick off our Health Innovations Series than with Alan D. Widgerow, Chief Scientific Officer at Galderma and Head of Innovation at Alastin Skincare. Alan began his career in South Africa, where he was in private practice for over 20 years. He is currently Division Chief of Research at UC Irvine Medical Center and it's evident from speaking with him that his passion lies in the laboratory. But interestingly enough, he might have never ended up there if not for a fateful phone call…Alan was all set to go into a career in dentistry when a phone call quite literally changed the trajectory of his life. A voice at the other end of the line encouraged him to follow his passions towards medical school and plastic surgery and Alan never looked back. Alan describes plastic surgery as an “amalgamation of creativity and science” and that no two cases are the same. It's easy to see what drew him to such an-ever evolving field and how he's still fascinated over 20 years later.To hear more about Alan D. Widgerow's career journey and to hear what book he's currently reading, tune in to this episode wherever you get your podcasts!  

Welcome to Becker's Healthcare Podcast, where we delve into the heart of healthcare innovations. In this episode, join us as we engage with Dr. Helen Egger, Co-founder and Chief Medical and Scientific Officer of Little Otter, a pioneering institution in children's mental health. Dr. Egger sheds light on the challenges hospitals and health systems encounter while addressing children's mental health needs. She unveils Little Otter's distinctive philosophy and methodology that emphasize early identification through dedicated resources and intricate processes. Discover the pivotal role telehealth's evolution has played in shaping Little Otter's practices. Tune in to grasp insightful steps that hospitals and health systems can adopt when treating children dealing with suicide ideation.

“We have this three-pound organ on the top of our bodies, our brains, that is a major evolutionary advantage, but it doesn't come with a user's manual…That's why I'm here.” Dr. David Spiegel, the Associate Chair of Psychiatry at Stanford University School of Medicine and Co-Founder/Chief Scientific Officer at Reveri, joins Corinna Bellizzi to take us deep into the emerging science of hypnotherapy as it relates to our health and wellness. With his background and expertise, he shows us how there is more to our overall well-being than meets the eye. In particular, he talks about how we can use hypnosis for healthy eating and achieving a better life. Follow along to this interesting conversation and discover the power of our minds to help us overcome the barriers that keep us from putting our best selves forward. Key takeaways from this episode:Misconceptions about hypnosisHow hypnotherapy can help people access their own superpowersHypnosis and long-term healthSelf-hypnosis with ReveriHypnotic Induction ProfileFor an exclusive 2 week All Access Pass to Reveri, just tap this link from your phone: reverihealth.app.link/nutrition Guest Social Links:Website: https://reveri.comGuest Profile: https://med.stanford.edu/profiles/david-spiegelInstagram: https://www.instagram.com/reveri/Medium: https://medium.com/reveriTwitter: https://twitter.com/reveri_healthFacebook: https://www.facebook.com/groups/5052869674822282

Not All Potential Drugs Get Their Day in the Sun. In this episode, David Katz talks about how this company focuses on developing medicines that can alleviate the side effects of existing medications, specifically in the context of steroids. He discusses the challenges of balancing commercial interests with scientific advancements, Sparrow Pharmaceuticals' strategy of acquiring deprioritized molecules, targeting HSD-1 for safer steroids, and their focus on Polymyalgia Rheumatica. Tune in and learn more about Sparrow Pharmaceutical's breakthrough approach to medication development! Click this link to the show notes, transcript, and resources: outcomesrocket.health

Dr. Omar Khan '90 shares with us his passion for research and why filling in the missing gaps in medicine is critical, his decision to enter the world of family medicine, and letting his life speak through his actions.

The Stock Day Podcast welcomed Panacea Life Sciences Holdings, Inc. (PLSH)(“the Company”), a holding company structured to develop and facilitate manufacturing, research, product development and distribution in the high-growth, natural human and animal health & wellness market segment. Chief Scientific Officer, James Baumgartner, PhD, joined Stock Day host Kevin Davis. 

Today's guest is Laurens Kruidenier, Chief Scientific Officer at Cellarity, a Flagship Pioneering company. Launched in 2019, Cellarity are fundamentally redesigning the way drugs are created. Unlike conventional drug discovery, which attempts to reduce disease to single causal targets, Cellarity's approach leverages a deep understanding of disease biology. The company's approach is a more robust path for drug creation because they target the whole cell—the complex, networked living system that is the ultimate integrator of human biology. The Cellarity platform provides critical insights into cellular dysfunction and reveals new biology that they can use to treat disease. This vantage point opens treatment avenues in countless diseases, including many that have been overlooked or have been too complex to resolve with traditional approaches. With programs in hematology, immuno-oncology and metabolism, Cellarity are pioneering a new generation of medicines. In the episode, Laurens will talk about: Interesting roles he's held over the years, The mission they are working on at Cellarity,  How they use AI and computational methods in drug discovery,  How the team is structured for success,  What excites him for the near future, and Why to consider a career with Cellarity

0:00 Intro 0:45 The founding of BioTx.ai 4:35 How do algorithms for ‘causal inference' work? 6:30 Modeling gene interactions for genetic disorders 8:35 How to predict gene interactions 10:30 What happens after identifying a potential gene variant or interaction? 14:35 How can you use machine learning to determine causal relationships between gene variants and disease? 17:30 Deconvoluting genes and traits, and their impacts on effect size 19:20 Key ingredients in determining causal relationships: data and computational power 21:10 Limitations of using machine learning to find genetic determinants of rare diseases 24:30 Predicting clinical outcomes with Biotx.ai 28:05 Machine learning enhances efficiency in the pre-clinical phase 29:40 Population genomics in Germany 32:50 Marco's career decisions – starting a company vs. continuing in academia 35:50 The pros and cons of industry 38:10 The gaps in industry and academia 41:20 Closing remarks

0:00 Intro 0:45 The founding of BioTx.ai 4:35 How do algorithms for ‘causal inference' work? 6:30 Modeling gene interactions for genetic disorders 8:35 How to predict gene interactions 10:30 What happens after identifying a potential gene variant or interaction? 14:35 How can you use machine learning to determine causal relationships between gene variants and disease? 17:30 Deconvoluting genes and traits, and their impacts on effect size 19:20 Key ingredients in determining causal relationships: data and computational power 21:10 Limitations of using machine learning to find genetic determinants of rare diseases 24:30 Predicting clinical outcomes with Biotx.ai 28:05 Machine learning enhances efficiency in the pre-clinical phase 29:40 Population genomics in Germany 32:50 Marco's career decisions – starting a company vs. continuing in academia 35:50 The pros and cons of industry 38:10 The gaps in industry and academia 41:20 Closing remarks

GORDON CHANG, Contributor, Gatestone Institute, Newsweek, Author, “The Coming Collapse of China,” “Nuclear Showdown: North Korea Takes the World, “Losing South Korea,” and “The Great US-China Tech War,” @Gordongchang Why are so many Chinese migrants coming to the United States? Why is the Biden administration not doing anything to stop the flow of migrants? Is China's economy on the decline? The World Health Organization's role in the COVID-19 pandemic PETER MCCULLOUGH, Board Certified Cardiovascular Diseases and Clinical Lipidology Expert, Former Chief Academic and Scientific Officer, St. John Providence Health System, President, Cardiorenal Society of America, @P_McCulloughMD How the narrative surrounding the origins of COVID-19 has shifted recently How long has the United States been working on vaccines related to coronaviruses? Why are vaccine companies "stonewalling" on the safety of their vaccines? Issues with booster shots for COVID-19 Was the WHO trying to cover up information about COVID-19?

The standard American diet doesn't often support people's gut health. Processed foods, imbalanced nutritional intake, and lifestyle stressors all contribute to a weakened gut microbiome. In this episode, Dr. Chris Damman, gastroenterologist and functional food expert, shares important findings on diet and the gut microbiome. He shares the importance of balancing your gut microbiome, what we can all do to live a healthier lifestyle, and more.Dr. Chris Damman formerly led the functional food and microbiome initiative at the Bill & Melinda Gates Foundation. and a Clinical Associate Professor at the University of Washington Department of Medicine and Global Health. He is a board-certified gastroenterologist and currently serves as the Chief Medical & Scientific Officer at Supergut, a company that makes prebiotic products that support the gut.Discussed in this episode:Health and diet standards in different populations and how it affects public healthWhy a balanced microbiome is so critical for health The biggest diet mistake people make that harms gut healthProcessed foods vs eating healthy in a busy society What causes gas?Why fiber supports the gut microbiomeHow gut health changes in different phases of someone's lifeAntibiotics, probiotics, and prebiotics in the gutThe Four F's, the Four M's, and the Big C“The gut is the gateway to health.” - Dr. Chris Damman

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.  This week Lewis Goldberg and Anne Donohoe are back for a new episode with special guest Nathan Bryson, PhD, Chief Scientific Officer of Reunion Neuroscience. Nathan joins us this week to discuss how he made his way to Reunion, the company's unique serotonergic psychedelic compound that's situated between psilocybin and DMT and designed to treat postpartum depression, goals of the neuroscience company and what he finds most intriguing about the discovery, creation and pathway to bringing novel compounds to market. If you are interested in learning more about Reunion or following the company's research and development progress, visit the links in our show notes. Also, be sure to follow Nathan and Reunion on LinkedIn, Twitter and Instagram. So sit back and enjoy our conversation with Nathan Bryson of Reunion Neuroscience.  Links and mentions in the show https://reunionneuro.com/  Links to the guest's company and social media accounts Reunion Neuroscience's Twitter: https://twitter.com/ReunionNeuro  Reunion Neuroscience's LinkedIn: https://www.linkedin.com/company/reunionneuro  Reunion Neuroscience's Instagram: https://www.instagram.com/reunionneuro/ Nathan's LinkedIn: https://www.linkedin.com/in/nathanbryson/   Show Credits: This episode was hosted by Lewis Goldberg and Anne Donohoe of KCSA Strategic Communications.  Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: Twitter: @The_GreenRush  Instagram: @thegreenrush_podcast LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/  Facebook: https://www.facebook.com/TheGreenRushPodcast/  YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Dr. Susanna Greer, Ph.D. is the Chief Scientific Officer of the V Foundation. In this role, Dr. Greer is a visionary ambassador of the V Foundation who works with our scientific advisory committee to steer funding to the most promising research opportunities. An accomplished strategist. She develops and articulates priorities to enhance the V Foundation's research portfolio, gifts, grants, and sponsorships. These are designed to advance the V Foundation's distinctive brand of cutting-edge and disruptive research. Susanna has spearheaded a grant of her own initiative for the V Foundation and will be leading our V Summit this month. Susanna, thank you for taking the time to join us.

Our Guest: Dr. Hamid Khoja, Chief Scientific Officer at FibroBiologicsWhat you'll get out of this episode: Dr. Khoja's background His background and an overview of FibroBiologics An overview of fibroblasts Fibroblasts in comparison to stem cells What diseases they are currently focused on and why? Where the company is at regarding clinical studies What's next? Our sponsors for this episode are Sage Growth Partners & FlipMDSage Growth Partners accelerates commercial success for healthcare organizations through a singular focus on growth. The company helps its clients thrive amid the complexities of a rapidly changing marketplace with deep domain expertise and an integrated application of research, strategy, and marketing. For more information, please go to www.sage-growth.com & follow Sage Growth Partners on social media - @sagegrowthpartnersFlipMD is an open, competitive marketplace of physicians only offering their consulting services to a wide range of client industries. The ultimate goal of flipMD is to be the best source of physician talent for any industry. The platform is very simple to use, you post a job for free with the specific scope of work and your budget. After the job posting, our physicians respond directly to you with their best offer for the work. Once you accept an offer, you fund the project. Once you receive satisfactory work, you accept and the funds are released to your expert physician consultant. For more information, please go to https://flip-md.com/ & follow FlipMD on social media - @flipmdTo learn more about FibroBiologics please use the links below:- Website - LinkedInAlso, be sure to follow Slice of Healthcare on our social channels:- Website - Facebook - LinkedIn - Twitter - YouTube - Newsletter

Gut health is a significant issue in a lot of men. Myself included. In fact, I have to strive to optimize my microbiome. Even though I'm doing a lot to be healthy, there's still more to be done. So in order to get some help, I have a special guest that will teach us about gut health and how to keep our immune system balanced. He's Dr. Chris Damman.Dr. Chris Damman is a practicing gastroenterologist who also works as a Clinical Associate Professor at the University of Washington. Furthermore, he is the Chief Medical & Scientific Officer at Supergut, a company developing functional foods that harness the microbiome to transform health. His areas of expertise include nutrition, metabolic health, and also prebiotics. In truth, it is an honor to have him as a guest on the podcast. It is most important to learn about digestive health, the gut, and why we need to focus on them. As a matter of fact, we need to take action on it. But we can't take action until we have enough knowledge and confidence to do so. Without a doubt, this episode will inspire you to take action right away. Not all at once, but little by little. Start by changing the type of foods you eat, exercising 3 to 4 days a week, and getting more outside. Both your gut and your mental health will thank you. “Mental health is such an underserved topic within medicine and general health. And we don't often realize just how profoundly our food and our microbes and our gut are impacting our brain.” —Dr. Chris Damman In This Episode: Definition of microbiomeImportance of butyrateThe connection between butyrate and metabolismFunctions of the mitochondriaWhy fiber has a positive effect on the gutCombination of supplements and whole foodsRole of community in our healthPrebiotics and probioticsWhere to start if you want to get healthierConnect with Dr Chris Damman:Supergut - https://linktr.ee/supergut_Faculty website – https://gastro.uw.edu/faculty/christopher-j-damman-md-maConnect with Funk Roberts: Website - https://www.over40alpha.com/ Instagram - https://www.instagram.com/funkrobertsfitnessSubscribe and Listen on iTuneshttps://podcasts.apple.com/ca/podcast/the-over-40-alpha-podcast/id1446632685 Listen to This Episode on Your Favourite Podcast Channelwww.over40alphapodcast.com

COL. (RET.) JOHN MILLS, Senior Fellow, Center for Security Policy, Member, Committee on the Present Danger: China Would China attack U.S. bases or Taiwan first in the event of a kinetic conflict? The significance of Xi Jinping and Vladimir Putin's recent meeting in Russia Financial tools the U.S. has at its disposal to counter China PETER MCCULLOUGH, Board Certified Cardiovascular Diseases and Clinical Lipidology Expert, Former Chief Academic and Scientific Officer, St. John Providence Health System, President, Cardiorenal Society of America, @P_McCulloughMD The immense political power of the World Health Organization and World Economic Forum A "shift" in treating COVID-19 in recent months Is the FDA trying to block information about the COVID vaccines? Were the COVID vaccines subject to the same standards as other vaccines in the past?

Marc Washington, Harvard MBA and former President of P90X, Beachbody, Shakeology and Dr. Chris Damman, Chief Medical, Scientific Officer and practicing gastroentologist join Ethan to discus gut health, our microbiome, and the clinical research that shows overall foundational health starts in our gut. Hosted on Acast. See acast.com/privacy for more information.

Much of the world's problems go back to food and public health. If we start treating food as more than the burst of flavors in our mouths and instead see it as medicine and a critical part of our health, the better we will be. Dr. Chris Damman greatly believes in this, diving even deeper to understand the science of gut health. He is the Chief Medical 6 Scientific Officer of Supergut and a board-certified, actively practicing gastroenterologist. In this episode, he sits down with Corinna Bellizzi to tell us more about the gut-brain axis and the importance of building and maintaining a healthy gut microbiome. Learn about the wisdom of your body as Dr. Chris navigates us through health, food, digestion, and nutrition. Follow along to this conversation for more! Key takeaways from this episode:· What is the gut-brain axis· What nutrients support the gut-brain axis· Why you should eat fermented foods· What is the difference between fiber and prebiotics· Why you should listen to your body Guest Social Links:Website: https://www.supergut.comInstagram: https://www.instagram.com/supergut/LinkedIn: https://www.linkedin.com/in/chris-damman/Gut Bites: https://gutbites.org/

The Trainwreck sits down with Ted Talk Speaker and Chief Scientific Officer from Redwire Company, Ken Savin, to discuss his work on the International Space Station, projects at Redwire and the life of a scientist. So climb aboard the Monthly Trainwreck and take a trip into deep space!!.... Rated as a Top 200 Comedic Interview Podcast!

It's uncommon for an embryologist to own equity in a clinic-lab company, at least here in the US. This week, Griffin hosts Alison Campbell to discuss where her career started, and how she earned her current role as an equity stakeholder and business influencer as the Chief Scientific Officer of the UK's largest fertility care provider, CARE Fertility. Listen to hear: What it is like when an embryologist becomes an equity partner of their group or practice. The unique advantages a lab director can bring to the practice. The potential for fertility clinic networks to become early-stage investors in fertility startups The differences in opportunities for embryologist education opportunities between the US and UK Dr. Campbell's viability test for companies that want to sell to CARE Fertility. What the 3-4 who advance to demo do to get there.

How's your gut health? Do you feel bloated or gassy?  Not to get too personal, but how's your stool? Are you often constipated? Or maybe you're on the other end of that spectrum and you're dealing with loose stool or diarrhea. Or maybe you suffer from frequent heartburn. Or maybe you're not sleeping well or are dealing with skin rashes and allergies. Do you often find yourself tired and sluggish throughout the day? Or maybe you have intense sugar cravings.  If any of these sound like you, these could be signs that you suffer from poor gut health. Stick around, in this episode we're going to deep dive into the world of the gut microbiome and give you tips on how to optimize your gut to make all other aspects of your life better! My guests today are Marc Washington and Dr. Chris Damman. Marc has spent his entire adult life in the fitness and nutrition industry. He was the president and CEO of Beach body, the CEO of Irwin Naturals, and is currently the founder and CEO of Supergut – a business designed to help people regain control of their health by harnessing the powerful science of the gut microbiome. Dr. Chris has spent his entire adult life studying the role of the gut microbiome and its relationship to overall health and vitality. He is currently the Chief Medical & Scientific Officer of Supergut. Join us today as we take a deep dive into your digestive health issues. We discuss the common ailments of the gut and their causes, as well as strategies for healing your gut microbiome for optimal health You can connect with Marc, Dr. Chris, and Supergut in the following ways: Website – www.supergut.com - Save 20% off your order with coupon code “silveredge”Twitter - @supergut_Facebook - @SupergutInstagram - @supergutTikTok - @SupergutYouTube - https://www.youtube.com/channel/UCjoeZaE3Nh4wQ3nwENgeFuA Sponsor Info – Levelswww.silveredgefree.comUse coupon code “KEV20” to save 20% off your order.  Want more over 50 health & wellness goodness? Check out our private Facebook group:https://www.facebook.com/groups/silveredgefitness

Both participation-focused OT and knowledge translation are hot topics in OT right now. And, in this one-hour course we will explore a research article that puts forth a knowledge translation roadmap to accelerate the uptake of participation-focused OT assessments and intervention. These are both big topics in their own right, and when you mesh them together it feels like more than one therapist can handle. Honestly, that's the point: Both knowledge translation and participation-focused OT are a team sport. It's going to take all of us to be both thinking differently as individuals and collaborating in new ways to solve problems for our clients. To help us unpack this journal article, and the practical implications for your OT practice, we are excited to welcome to the podcast our guest, Satvika Garg, PhD, OTR/L, Scientific Officer at the American Occupational Therapy Foundation.In order to earn credit for this course, you must take the test within the OT Potential Club.You can find more details on this course here:https://otpotential.com/ceu-podcast-courses/participation-focused-knowledge-translation-in-pediatric-otHere's the primary research we are discussing:Anaby, D., Khetani, M., Piskur, B., van der Holst, M., Bedell, G., Schakel, F., de Kloet, A., Simeonsson, R., &; Imms, C. (2021). Towards a paradigm shift in pediatric rehabilitation: Accelerating the uptake of evidence on participation into routine clinical practice. Disability and Rehabilitation, 44(9), 1746–1757. Support the show

Today we are tackling a topic that is crucial to the success of many companies when they go from startup to the next phase of growth. It's the question that many founders especially technical founders or scientific founders who start as CEO's have to ask themselves at some point. When is it time to bring in a new CEO? How do you find the right CEO? And how do you set up the partnership for success.To help us answer the questions we have Gil Blander, Founder and Scientific Officer of InsideTracker, and Rony Sellam, the CEO.InsideTracker is a company that by tracking our biomarkers what's inside us, blood and DNA, leverages science and technology to provide personalized solutions that allow people to improve their overall quality of life and longevity.KEY TAKEAWAYS [01:34] - How you find the right CEO for your company when you are a Founder. [03:12] - Gil introduces himself.[03:39] - Gil shares his fascination with the aging process and the inspiration and concept behind InsideTracker. [04:30] - Rony introduces himself and shares his background and why he wanted to get involved with Inside Tracker. [05:57] - Gil shares some of the challenges—from financial to people management—of starting a business as a scientist and someone unfamiliar with managing a company. [06:42] - Gil shares the keys he held onto to be a successful leader when he was first starting InsideTracker. [07:31] - Rony shares the value of having mentors and how the lessons he learned from other captains of industry taught him the importance of vision, mission, and values. [08:43] - How a heavy dose of humility helps grow successful leaders. [10:29] - Gil explains that in the company's early stages, he emphasized the science making it the foundation of its activities while remaining profitable. [13:00] - Gil describes his goal of finding a CEO for the company from the start and the consideration he put into finding the right fit for that role.[16:10] - The need for two different roles to take a company with a strong scientific backbone and turn it into an impactful business. [17:35] - Rony shares how his desire to work with a company that is helping people live better and longer played into his decision to become CEO of InsideTracker. [18:09] - How InsideTracker uses personalized, science-backed information to help individuals take control of their health from the Inside out. [20:49] - The significance of maintaining a solid scientific foundation within a science-based company.[22:05] - Rony recounts the two things that impressed him the most when he initially met with Gil.[25:04] - Gil highlights the two most important criteria he sought in a CEO for InsideTracker.[26:03] - Sharing stories of the Sunday Scaries and how that doesn't apply to Gil and Rony's partnership.[27:34] - Rony shares how they formulated the rules of engagement for their relationship, established trust, and the surprising key to solving more problems.[31:35] - Rony shares why it's vital to establish and stick with the chain of command in a business. [32:01] - Gil shares how having a sounding board helped him transition the role of CEO to Rony (and why he continues to have a coach in his corner). [34:23] - The costs and constraints of upholding the values of being

Andy brings you information directly from the source to let you know what to expect when the antivirals arrive: who will get them, how to get them, when to get yours, and the biggest question — will they change everything? In an exclusive interview with In the Bubble, Dr. David Kessler, Chief Science Officer of the White House COVID-19 Response Team, tells Andy how he is personally navigating Omicron and what the Biden Administration is doing to ensure that we have the capacity to respond quickly to the next pandemic.    Keep up with Andy on Twitter @ASlavitt and Instagram @andyslavitt.    Follow David @DavidAKesslerMD on Twitter.   Joining Lemonada Premium is a great way to support our show and get bonus content. Subscribe today at bit.ly/lemonadapremium.    Support the show by checking out our sponsors!   Click this link for a list of current sponsors and discount codes for this show and all Lemonada shows: https://lemonadamedia.com/sponsors/  Throughout the pandemic, CVS Health has been there, bringing quality, affordable health care closer to home—so it's never out of reach for anyone. Because at CVS Health, healthier happens together. Learn more at cvshealth.com.   Check out these resources from today's episode:    Learn more about the NIH's COVID-19 treatment guidelines: https://www.covid19treatmentguidelines.nih.gov/ Check out the New England Journal of Medicine article on Remdesivir that David mentions in today's episode: https://www.nejm.org/doi/full/10.1056/NEJMoa2116846 Find a COVID-19 vaccine site near you: https://www.vaccines.gov/  Order Andy's book, Preventable: The Inside Story of How Leadership Failures, Politics, and Selfishness Doomed the U.S. Coronavirus Response: https://us.macmillan.com/books/9781250770165    Stay up to date with us on Twitter, Facebook, and Instagram at @LemonadaMedia.    For additional resources, information, and a transcript of the episode, visit lemonadamedia.com/show/inthebubble. See omnystudio.com/listener for privacy information.